Staff by Division

Staff Biography

Jonathan Glass, MD

Professor of Medicine
Carroll W. Feist-Professor of Cancer Research
Chief, Section of Hematology and Oncology
Director, Feist-Weiller Cancer Center

Feist-Weiller Cancer Center
LSU Health Sciences Center
1501 Kings Hwy
P.O. Box 33932
Shreveport, LA 71130-3932

Contact

Phone: (318) 813-1057
Fax: (318) 813 1055
JGlass@lsuhsc.edu

Team Membership

Hematology Team
Blood and Marrow Transplant Program

Clinical Expertise / Education / Board Certifications / Professional Associations / Research / Publications

Clinical Expertise

Jonathan Glass, MD is the founding Director of the Feist-Weiller Cancer Center at LSU Health Sciences Center- Shreveport. Dr. Glass has considerable experience and expertise in hematologic malignancies including lymphomas, leukemias, and plasma cell disorders (for all of which he has active studies); non-malignant hematologic disorders (such as TTP, hemolytic anemias and hemochromatosis); as well as general oncology. Dr. Glass has been Chief of the Section of Hematology-Oncology since 1986, Director of the Cancer Center since its inception in 1993, and he has overseen the growth of the Section and the Cancer Center to its current status as a premier center for clinical cancer research studies. He is internationally known for his research activities in iron metabolism and also investigation of transcription factor abnormalities in prostate cancer.

Education / Professional Experience

1962	B.S., Massachusetts Institute of Technology
1966	M.D., Harvard Medical School

Internship and Residencies:
1966 - 1967	Intern in Medicine, Hospital of the University of Pennsylvania
1969 - 1970	Assistant Resident in Medicine, Peter Bent Brigham Hospital, Boston, Massachusetts

Fellowship:
1967 - 1969	Staff Associate, Laboratory of Biochemical Genetics, National Heart Institute, National Institutes of Health
1970 - 1972	Clinical Fellow in Medicine (Hematology and Oncology), Beth Israel Hospital and Harvard Medical School

Academic Appointments:
	1972 - 1977	Instructor in Medicine, Harvard Medical School
	1977 - 1986	Assistant Professor of Medicine, Harvard Medical School
	1986 - 1991	Associate Professor of Medicine and Chief, Section of Hematology/Oncology, LSU Medical Center
	1991 -	Professor of Medicine and Chief, Section of Hematology/Oncology, LSU Health Sciences Center
	1991 -	Director, Feist-Weiller Cancer Center (formerly Center for Excellence in Cancer Research), LSU Health Sciences Center
	1999- 2000	Visiting Professor of Medicine, Harvard Institutes of Medicine, Harvard Medical School
	2002 -	Carroll W. Feist Professor of Cancer Research
Hospital Appointments:
	1972 - 1974	Assistant in Medicine, Beth Israel Hospital
	1972 - 1978	Consultant in Hematology, Pondville Hospital
	1974 - 1986	Associate in Medicine, Beth Israel Hospital
	1978 - 1980	Director, Clinical Hematology Laboratory, Beth Israel Hospital
	1986 -	Attending Physician, LSU Medical Center
	1986 -	Consultant, VA Hospital, Shreveport
Other Professional Positions and Major Visiting Appointments:
	1972 - 1974	Research Fellowship, Medical Foundation, Inc., Boston, Massachusetts
	1975 - 1977	Special Fellow of the Leukemia Society of America, Inc.
	1976 - 1985	Program Coordinator, Office of Continuing Education for Harvard Medical School, Hale Hospital, Haverhill, Massachusetts
	1977 - 1983	Research Career Development Awardee, National Institutes of Health, Bethesda, Maryland

Board Certifications

1971	American Board of Internal Medicine
1972	American Board of Internal Medicine Subspecialty Board in Hematology

Professional Associations

	1975 - present	American Federation for Clinical Research
	1976 - present	American Society of Hematology
	1977 - present	International Society for Experimental Hematology
	1978 - 1986	Society for Experimental Medicine and Biology
	1980 - 1983	Committee on Nutritional Anemias, American Society of Hematology
	1987 - 1995	Louisiana Cancer Consortium, Director
	1987 - present	Southern Society for Clinical Investigation
	1987 - 1994	American Cancer Society, Director of Caddo-Bossier Board
	1988 - 1991	Northwest Louisiana Biomedical Research Foundation, Director
	1990 - present	American Society for Biochemistry and Molecular Biology
	1994 - present	American Association of Cancer Research
	2000 - present	Member, Board of Directors, Louisiana Lung and Cancer Trust Fund

Research Interest

	Cellular and molecular mechanisms of iron transport in erythroid precursors.
	Molecular mechanisms of metal transport across enterocytes.

Selected Publications

Ma Y, Yeh M, Yeh KY, Glass J. Iron Imports. V. Transport of iron through the intestinal epithelium. Am J Physiol Gastrointest Liver Physiol. 2006 Mar;290(3):G417-22.

Fowler M, Borazanci E, McGhee L, Pylant SW, Williams BJ, Glass J, Davis JN, Meyers S. RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region. J Cell Biochem.97:1-17, 2006.

Yin H, Glass, J. In prostate cancer cells the interaction of C/EBP alpha with Ku70, Ku80, and PARP-1 increases sensitivity to DNA damage. J Biol Chem. 281:11496-505, 2006. Epub 2006 Feb 20.

Dalal S, Boddapati M, Lowery MN, Veillon DM, Glass J, Munker R. Treatment of acute myeloid leukemia in a Jehovah's Witness. Ann Hematol. 85:407- 8, 2006.

Sattar T, Griffeth LK, Latifi HR, Glass J, Munker R, Lilien DL. PET imaging today: contribution to the initial staging and prognosis of patients with non-Hodgkin's lymphomas. J La State Med Soc. 158:193-201, 2006.

Yin H, Radomska HS, Tenen DG, Glass J. Down regulation of PSA by C/EBPa is associated with loss of AR expression and inhibition of PSA promoter activity in the LNCaP Cell Line. BMC Cancer. 6:158, 2006.

Yin H, Glass J, Blanchard KL. MOZ-TIF2 repression of nuclear receptor-mediated transcription requires multiple domains in MOZ and in the CID domain of TIF2. Mol Cancer. 6:51, 2007.